|
answer text |
<p>The 2019 Voluntary Scheme for Branded Medicines Pricing and Access, and the statutory
scheme for branded medicines pricing, work together to control the cost of branded
medicines to the National Health Service and ensure it stays within affordable limits.</p><p>
</p><p>The 2019 Voluntary Scheme began on 1 January 2019 and will run for five years
until the end of 2023. The Voluntary Scheme aims to provide stability and predictability
for all parties in terms of the United Kingdom’s branded medicines expenditure and
the medicines pricing and access environment for the period 2019 to 2023. It also
aims to achieve a balance between patient access, affordability and supporting the
development of innovative new medicines, including support for small companies.</p>
|
|